369
Participants
Start Date
October 31, 2008
Primary Completion Date
November 30, 2010
Study Completion Date
December 31, 2012
PAZOPANIB
800 mg once daily orally
Placebo
matching placebo 800 mg once daily orally
GSK Investigational Site, Brussels
GSK Investigational Site, Brussels
GSK Investigational Site, Randwick
GSK Investigational Site, Leuven
GSK Investigational Site, Box Hill
GSK Investigational Site, Liège
GSK Investigational Site, Woolloongabba
GSK Investigational Site, Kurralta Park
GSK Investigational Site, Nedlands
GSK Investigational Site, Hobart
GSK Investigational Site, Ghent
GSK Investigational Site, Candiolo (TO)
GSK Investigational Site, Turin
GSK Investigational Site, Marseille
GSK Investigational Site, Bad Saarow
GSK Investigational Site, Philadelphia
GSK Investigational Site, Rozzano (MI)
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Hanover
GSK Investigational Site, Bordeaux
GSK Investigational Site, Birmingham
GSK Investigational Site, Saint-Priest-en-Jarez
GSK Investigational Site, Clevand
GSK Investigational Site, Essen
GSK Investigational Site, Valencia
GSK Investigational Site, Cologne
GSK Investigational Site, Vandœuvre-lès-Nancy
GSK Investigational Site, Minneapolis
GSK Investigational Site, Lille
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Chicago
GSK Investigational Site, Mannheim
GSK Investigational Site, Heidelberg
GSK Investigational Site, Lyon
GSK Investigational Site, Paris
GSK Investigational Site, Napoli
GSK Investigational Site, Los Angeles
GSK Investigational Site, Santa Monica
GSK Investigational Site, Orange
GSK Investigational Site, Villejuif
GSK Investigational Site, Boston
GSK Investigational Site, Boston
GSK Investigational Site, Herlev
GSK Investigational Site, Dresden
GSK Investigational Site, Rome
GSK Investigational Site, Terni
GSK Investigational Site, Aichi
GSK Investigational Site, Chiba
GSK Investigational Site, Fukuoka
GSK Investigational Site, Hokkaido
GSK Investigational Site, Mie
GSK Investigational Site, Okayama
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Tokyo
GSK Investigational Site, Amsterdam
GSK Investigational Site, Groningen
GSK Investigational Site, Leiden
GSK Investigational Site, Nijmegen
GSK Investigational Site, Rotterdam
GSK Investigational Site, Daegu
GSK Investigational Site, Goyang-si, Gyeonggi-do
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Palma de Mallorca
GSK Investigational Site, Gothenburg
GSK Investigational Site, Linköping
GSK Investigational Site, Lund
GSK Investigational Site, Umeå
GSK Investigational Site, Uppsala
GSK Investigational Site, Manchester
GSK Investigational Site, Glasgow
GSK Investigational Site, Leeds
GSK Investigational Site, London
GSK Investigational Site, Nottingham
GSK Investigational Site, Sheffield
Lead Sponsor
GlaxoSmithKline
INDUSTRY